This benefit persisted throughout the four-year study period, suggesting semaglutide does not just help you lose weight but actively protects your cardiovascular system
Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with CVD and either obesity or overweight, John Sharretts, MD, director of the division of diabetes, lipid disorders and obesity in the FDAs Center for Drug Evaluation and Research, said in the statement
Its hypothesized roles span pigmentation pathways, neuronal signaling, and models of regenerative biology
These groundbreaking treatments are designed to help you shed those stubborn pounds and achieve the body youve always dreamed ofsafely and effectively
The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa